📖 Approx. 3 minutes ／ Updated 2026.06.11
In this article, an M&A advisor specializing in the healthcare industry explains from a practical perspective how business transfers become key discussion points in pulmonology business succession and medical M&A. We will share specific strategies considering home oxygen therapy (HOT) patients, bronchoscopy equipment, and the carve-out/transfer of specific business units.
1. Industry Background of Business Transfers in Pulmonology
According to the Dynamic Survey of Medical Institutions by the Ministry of Health, Labour and Welfare, the business environment for medical institutions, including pulmonology clinics, has become increasingly challenging in recent years due to a combination of factors such as medical fee revisions, rising labor costs, and the burden of capital investment. In particular, interest in third-party succession M&A is growing from the perspective of home oxygen therapy patients and bronchoscopy equipment.
At the same time, business transfers are a crucial topic in medical M&A practice. By appropriately designing the carve-out and transfer of specific business units, a succession that benefits both the transferor and the transferee can be achieved.
2. Key Practical Points
- Preparation: Organize the workflow, patient base, and equipment status unique to pulmonology, and clarify the terms of the transfer.
- Valuation: Calculate an appropriate transaction value range based on the characteristics of the clinical department. In pulmonology, home oxygen therapy patients and bronchoscopy equipment are key factors in the valuation.
- Structuring the Business Transfer: Select the optimal scheme considering the carve-out and transfer of specific business units. Verification from tax, legal, and labor perspectives is also required.
- Buyer Search & Matching: Select prospective buyers matching the clinical department’s characteristics from a nationwide network. Carefully align the desired terms and conditions of both parties.
- Due Diligence: Conduct thorough investigations from financial, legal, labor, and clinical practice perspectives. Confirm pulmonology-specific permits, licenses, and facility standards.
- Final Agreement & Closing: Execute the final agreement, including representations, warranties, and indemnification clauses. Proceed with the transfer of permits/licenses and staff notifications in parallel.
3. Specific Considerations in Pulmonology
In the M&A of pulmonology medical institutions, home oxygen therapy patients and bronchoscopy equipment hold the key to a successful succession. There are numerous specific issues depending on the characteristics of the clinical department, such as the continuity of the patient base, retention of staff (physicians, nurses, and co-medicals), equipment condition and replacement plans, and the maintenance or acquisition of facility standards.
Furthermore, strategic design based on market characteristics unique to pulmonology—such as the mix of insurance-covered and self-pay treatments, the status of regional medical cooperation, and relationships with neighboring competing medical institutions—is essential. Leveraging our track record in supporting pulmonology successions, we assist with practical operations from an industry-specialized perspective.
4. Practical Details of Business Transfers
Business transfers are an area requiring specialized consideration in medical M&A. Designing the transaction with a focus on the carve-out and transfer of specific business units is the key to success.
- Review of Relevant Laws and Practical Standards: Alignment with the Medical Care Act, tax laws, and labor regulations.
- Collaboration with Experts: Working together with certified public accountants, tax accountants, attorneys, and labor attorneys.
- Risk Assessment: Identifying potential risks and formulating mitigation strategies.
- Consensus Building Between Parties: Designing terms that are mutually acceptable to both the transferor and the transferee.
- Proper Documentation: Clearly specifying terms in the letter of intent (LOI) and final agreement.
Frequently Asked Questions
Q. What documents are required for the initial consultation?
A. It will facilitate a smoother process if you can prepare financial statements for the last three fiscal years, patient volume trends, staff composition, equipment lists, and lease agreements (if applicable) in advance. We will collect these after executing a non-disclosure agreement (NDA).
Q. What is the typical market price range for transferring a pulmonology practice?
A. For pulmonology, home oxygen therapy patients and bronchoscopy equipment serve as key valuation metrics. As a general guideline, clinics without beds are valued at 0.5 to 1.5 times annual revenue, while clinics with beds or hospital-scale facilities are valued at 3 to 7 times EBITDA. We can provide more details through our free preliminary valuation.
Q. What should I keep in mind when proceeding with a business transfer?
A. Prior planning that accounts for the carve-out and transfer of specific business units is essential. Collaborating with experts to ensure seamless execution without omissions is the key to success.
Q. Will my staff or patients find out about the consultation?
A. Information is disclosed only to a limited extent after signing an NDA, and no disclosure is made to stakeholders before the final agreement. We strictly maintain absolute confidentiality.
Related Columns
- Complete Guide to Business Succession for Hospitals and Medical Corporations: From Successor Shortages to Success Stories in Medical M&A Practice
- Complete Guide to Clinic Sales and Transfers: Market Prices, Process, and Key Considerations Explained by Medical M&A Experts
- How to Proceed with Medical M&A and Hospital Succession: 6 Steps from Consultation to Closing Explained with Real Examples
- Complete Guide to Tax Schemes in Medical Corporation M&A: Key Discussion Points for Tax Accountants and CPAs
Contact M&A Medical for Consultations on Pulmonology Business Transfers
Strict Confidentiality • Free Initial Consultation • Success-Fee Based